Netherlands-based Qiagen has struck a deal to buy Irvine, CA-based eGene for $34 million, adding a genetic analysis system that it says will improve lab productivity. EGene has developed and is commercializing a patented sample separation and analysis technology based on capillary electrophoresis. Release